Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Enrolling by invitation Not applicable

The Effect of Diabetes Education Given With Video Animation on Metabolic Control, Self-Care Ability, and Attitudes Towards the Disease in Children With Type 1 Diabetes

NCT07107789 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2025-08-15
Last updated
2025-08-06

Condition(s) studied

Type 1 Diabetes in Children

Investigational drug(s) / intervention(s)

Diabetes education with video animation

Diabetes education with video animation: Providing diabetes education to the experimental group through a video animation Following the routine diabetes education provided by the hospital, the experimental group will receive diabetes education using a video animation prepared and staged by the researcher and approved by experts.

Study summary

The aim of this study is to evaluate the attitude towards the disease, perceived social support systems, metabolic control and self-care ability of pediatric patients diagnosed with Type 1 diabetes, by giving video animation training considering their age and developmental level. The main questions it aims to answer are:

1. Nursing interventions using video animations increase self-care abilities in children aged 11-18.
2. Nursing interventions using video animations increase the perception of social support in children aged 11-18.
3. Nursing interventions using video animations support metabolic control in children aged 11-18.
4. Nursing interventions using video animations positively affect the attitudes of children aged 11-18 toward their illness.

Eligibility

Sex
ALL
Min age
11 Years
Max age
18 Years
Healthy volunteers
No
Inclusion Criteria: * Agreeing to participate in the study * Diagnosed with Type 1 DM by a specialist * Diagnosed with Type 1 diabetes for at least 6 months * Being between the ages of 11 and 18 * Using an insulin pen * Not using an insulin pump * Coming for regular checkups at the Pediatric Endocrinology clinic * Having no other chronic disease besides diabetes Exclusion Criteria: * Using an insulin pump * Not being mentally healthy * Having any mental or physical disability

Primary outcome measure(s)

  • Metabolic Control — three weeks
    Weight and height measurements will be combined to report body mass index in kg/m². Fasting and postprandial blood glucose values and HbA1C values will be evaluated.
  • Self-care power — three weeks
    The five-point Likert-type self-care agency scale, which offers an opportunity for self-assessment, consists of 35 questions. The total score obtained from the scale ranges from 35 to 140. A higher total score indicates that the patient is more independent and competent in self-care.
  • Attitude Towards One's Own Illness — three weeks
    It provides an opportunity to assess the attitudes children with chronic illness develop toward their illness. A 13-item, five-point Likert-type scale was designed to self-report children with chronic illnesses. Four of the 13 items are bipolar (very good, somewhat good, not sure, somewhat bad, very bad), while nine items assess how often children experience positive or negative feelings specific to having a chronic illness, using the phrases "very often, often, sometimes, not often, never." Mean scores for items measuring children's attitudes toward their illnesses range from 1 to 5. The lowest possible total score is 13, and the highest is 65. There are no reverse items. Scores of 1 and 2 indicate a negative attitude, 3 indicate a neutral attitude, and 4 and 5 indicate a positive attitude. The internal consistency coefficient of the scale was determined to be 0.79.
  • Multifaceted Perceived Social Support — three weeks
    The total score available ranges from 12 to 84. A higher score indicates a positive perception of social support.

Trial sites (1)

FacilityCityRegionStatus
Erzurum City Hospital Erzurum Palandöken
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07107789 on ClinicalTrials.gov ↗ ← All trials in Turkey